1. Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review

   • David García-Azorín
   • Katrin M. Seeher
   • Matilde Leonardi

   Review Open access 22 May 2021 Pages: 3947 - 3960

   

2. Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus

   • Diego Centonze
   • Maria A. Rocca
   • Massimo Filippi

   Original Communication Open access 12 April 2021 Pages: 3961 - 3968

3. Serum neurofilament light chain (sNfL) values in a large cross-sectional population of children with asymptomatic to moderate COVID-19

   • Tobias Geis
   • Susanne Brandstetter
   • CoKiBa Study group

   Original Communication Open access 23 April 2021 Pages: 3969 - 3974

   

4. Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19?

   • Mario Orrico
   • Agostino Nozzolillo
   • Lucia Moiola

   Original Communication 14 April 2021 Pages: 3975 - 3979

   

5. SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients

   • Mauro Morassi
   • Francesco Palmerini
   • Alberto Vogrig

   Original Communication 21 April 2021 Pages: 3980 - 3987

   

6. Management considerations for stroke-like episodes in MELAS with concurrent COVID-19 infection

   • Kuntal Sen
   • Dana Harrar
   • Andrea L. Gropman

   Short Commentary 01 April 2021 Pages: 3988 - 3991

   

7. Neurosensory dysphagia in a COVID-19 patient

   • Alessia Zanon
   • Laura Cacciaguerra
   • Massimo Filippi

   Letter to the Editors 19 April 2021 Pages: 3992 - 3994

   

8. Palilalia as a prominent feature of anti-NMDA receptor encephalitis in a woman with COVID-19

   • Andrew W. McHattie
   • Jan Coebergh
   • Francesca Morgante

   Letter to the Editors 08 April 2021 Pages: 3995 - 3997

   

9. Comment on the paper Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab: the likely explanation for this phenomenon based on our observations

   • Hubert Mado
   • Monika Adamczyk-Sowa

   Letter to the Editors 16 April 2021 Pages: 3998 - 3999

10. Spontaneous spinal cord ischemia during COVID-19 infection

    • Francesco Bax
    • Gian Luigi Gigli
    • Mariarosaria Valente

    Letter to the Editors 28 April 2021 Pages: 4000 - 4001

    

11. Wake-up stroke: imaging-based diagnosis and recanalization therapy

    • Yu-Lei Zhang
    • Jun-Fang Zhang
    • Yun-Cheng Wu

    Review 15 July 2020 Pages: 4002 - 4012

12. Repetitive transcranial magnetic stimulation as an alternative therapy for stroke with spasticity: a systematic review and meta-analysis

    • Peng Xu
    • Yan Huang
    • Baojun Wang

    Review 11 July 2020 Pages: 4013 - 4022

    

13. The specific pattern of retinal nerve fiber layer thinning in Parkinson’s disease: a systematic review and meta-analysis

    • Lele Huang
    • Chen Wang
    • Ruijun Zhang

    Review 20 July 2020 Pages: 4023 - 4032

    

14. Managing disorders of consciousness: the role of electroencephalography

    • Yang Bai
    • Yajun Lin
    • Ulf Ziemann

    Review Open access 11 September 2020 Pages: 4033 - 4065

    

15. A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications

    • Larissa Hauer
    • Julian Perneczky
    • Johann Sellner

    Review Open access 27 July 2020 Pages: 4066 - 4077

    

16. Role of aquaporins in hydrocephalus: what do we know and where do we stand? A systematic review

    • Camilla de Laurentis
    • Paola Cristaldi
    • Andrea Di Cristofori

    Review 03 August 2020 Pages: 4078 - 4094

    

17. Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential

    • Junsheng Li
    • Qian Zhang
    • Jizong Zhao

    Review 06 August 2020 Pages: 4095 - 4107

18. Impact of leukoaraiosis severity on the association of outcomes of mechanical thrombectomy for acute ischemic stroke: a systematic review and a meta-analysis

    • Longwen Huo
    • Penghui Chen
    • Shouchun Wang

    Review Open access 28 August 2020 Pages: 4108 - 4116

    

19. Risk factors for benign paroxysmal positional vertigo recurrence: a systematic review and meta-analysis

    • Jinbao Chen
    • Senlin Zhang
    • Chuxuan Liu

    Review 24 August 2020 Pages: 4117 - 4127

    

20. Efficacy of acupuncture for migraine prophylaxis: a trial sequential meta-analysis

    • Shi-Qi Fan
    • Song Jin
    • Hui Zheng

    Review 24 August 2020 Pages: 4128 - 4137

    

21. Prevalence of freezing of gait in Parkinson’s disease: a systematic review and meta-analysis

    • Wei-Shan Zhang
    • Chao Gao
    • Sheng-Di Chen

    Review 08 July 2021 Pages: 4138 - 4150

    

22. Correction to: Prevalence of freezing of gait in Parkinson’s disease: a systematic review and meta-analysis

    • Wei-Shan Zhang
    • Chao Gao
    • Sheng-Di Chen

    Correction 24 August 2021 Pages: 4151 - 4151

23. Thalamic versus midbrain tremor; two distinct types of Holmes’ Tremor: a review of 17 cases

    • N. Nsengiyumva
    • A. Barakat
    • S. H. Alusi

    Original Communication 11 May 2021 Pages: 4152 - 4162

24. Cerebellar ataxia and myeloradiculopathy associated with AP3B2 antibody: a case report and literature review

    • Liu Mange
    • Ren Haitao
    • Guan Hongzhi

    Original Communication 14 May 2021 Pages: 4163 - 4169

    

25. The known burden of Huntington disease in the North of Scotland: prevalence of manifest and identified pre-symptomatic gene expansion carriers in the molecular era

    • Georgios Kounidas
    • Heather Cruickshank
    • Zosia Miedzybrodzka

    Original Communication Open access 15 April 2021 Pages: 4170 - 4177

    

26. Longitudinal structural brain changes in Friedreich ataxia depend on disease severity: the IMAGE-FRDA study

    • Louisa P. Selvadurai
    • Nellie Georgiou-Karistianis
    • Louise A. Corben

    Original Communication 15 April 2021 Pages: 4178 - 4189

    

27. Cancer is associated with inferior outcome in patients with ischemic stroke

    • Katharina Seystahl
    • Alessia Hug
    • Michael Weller

    Original Communication Open access 04 May 2021 Pages: 4190 - 4202

    

28. Baseline cognitive profile is closely associated with long-term motor prognosis in newly diagnosed Parkinson’s disease

    • Seok Jong Chung
    • Han Soo Yoo
    • Phil Hyu Lee

    Original Communication 04 May 2021 Pages: 4203 - 4212

    

29. Stroke-unit care for stroke patients in China: the results from Bigdata Observatory platform for Stroke of China

    • Wen-Jun Tu
    • Feng Yan
    • Longde Wang

    Original Communication 22 April 2021 Pages: 4213 - 4220

    

30. Assessment of muscular strength and functional capacity in the juvenile and adult myotonic dystrophy type 1 population: a 3-year follow-up study

    • Marie-Pier Roussel
    • Marie-Michèle Fiset
    • Elise Duchesne

    Original Communication 27 April 2021 Pages: 4221 - 4237

    

31. Neuropsychological and neuroimaging characteristics of classical superficial siderosis

    • Edgar Chan
    • Yezen Sammaraiee
    • David J. Werring

    Original Communication 17 April 2021 Pages: 4238 - 4247

    

32. Prognostic value of ‘late’ electroencephalography recordings in patients with cardiopulmonal resuscitation after cardiac arrest

    • Jakob I. Doerrfuss
    • Alexander B. Kowski
    • Christian Storm

    Original Communication Open access 19 April 2021 Pages: 4248 - 4257

    

33. Structural MRI substrate of long-duration response to levodopa in Parkinson’s disease: an exploratory study

    • Giulia Donzuso
    • Giorgia Sciacca
    • Mario Zappia

    Original Communication Open access 17 April 2021 Pages: 4258 - 4264

    

34. Association between neurosarcoidosis with autonomic dysfunction and anti-ganglionic acetylcholine receptor antibodies

    • Makoto Oishi
    • Akihiro Mukaino
    • Shunya Nakane

    Original Communication Open access 21 April 2021 Pages: 4265 - 4279

    

35. RFC1 AAGGG repeat expansion masquerading as Chronic Idiopathic Axonal Polyneuropathy

    • Matteo Tagliapietra
    • Davide Cardellini
    • Gian Maria Fabrizi

    Original Communication Open access 21 April 2021 Pages: 4280 - 4290

    

36. High prevalence of serum anti-NH₂-terminal of α-enolase antibodies in patients with multiple system atrophy and corticobasal syndrome

    • Akio Kikuchi
    • Makoto Yoneda
    • Masashi Aoki

    Original Communication 15 April 2021 Pages: 4291 - 4295

37. Epilepsy and episodic ataxia type 2: family study and review of the literature

    • Lorenzo Verriello
    • Giada Pauletto
    • Gian Luigi Gigli

    Original Communication 13 May 2021 Pages: 4296 - 4302

    

38. Long-term outcome and predictors of long-term disease activity in natalizumab-treated patients with multiple sclerosis: real life data from the Austrian MS Treatment Registry

    • Michael Guger
    • Christian Enzinger
    • the Austrian MS Treatment Registry (AMSTR)

    Original Communication Open access 22 April 2021 Pages: 4303 - 4310

    

39. Visual evoked potential latency predicts cognitive function in people with multiple sclerosis

    • Thomas J. Covey
    • Daniel Golan
    • Mark Gudesblatt

    Original Communication 18 April 2021 Pages: 4311 - 4320

    

40. Respiratory parameters on diagnostic sleep studies predict survival in patients with amyotrophic lateral sclerosis

    • Markus Engel
    • Christian Glatz
    • Matthias Boentert

    Original Communication Open access 20 April 2021 Pages: 4321 - 4331

    

41. Daytime sleepiness might increase the risk of ALS: a 2-sample Mendelian randomization study

    • Gan Zhang
    • Linjing Zhang
    • Dongsheng Fan

    Original Communication 29 April 2021 Pages: 4332 - 4339

    

42. Frequency, clinical presentation and outcome of vigilance impairment in patients with uni- and bilateral ischemic infarction of the paramedian thalamus

    • Merve Fritsch
    • Kersten Villringer
    • Christian H. Nolte

    Original Communication Open access 21 April 2021 Pages: 4340 - 4348

    

43. Saliva RNA biomarkers predict concussion duration and detect symptom recovery: a comparison with balance and cognitive testing

    • Gregory Fedorchak
    • Aakanksha Rangnekar
    • Steven Hicks

    Original Communication Open access 24 May 2021 Pages: 4349 - 4361

    

44. Sleep disturbances in craniopharyngioma: a challenging diagnosis

    • Ramona Cordani
    • Marco Veneruso
    • Lino Nobili

    Original Communication Open access 14 September 2021 Pages: 4362 - 4369

    

45. Correction to: Sleep disturbances in craniopharyngioma: a challenging diagnosis

    • Ramona Cordani
    • Marco Veneruso
    • Lino Nobili

    Correction Open access 24 September 2021 Pages: 4370 - 4370

46. A dorsolateral medullary lesion causing persistent down-beating nystagmus

    • Allison S. Young
    • Stephen W. Reddel
    • Miriam S. Welgampola

    Letter to the Editors 09 August 2021 Pages: 4371 - 4373

    

47. CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient

    • Ann-Kathrin Kogel
    • Ralf Gold
    • Ruth Schneider

    Letter to the Editors Open access 27 June 2021 Pages: 4374 - 4375

48. Cutaneous diseases related to a hyperactive T-cell response in ocrelizumab-treated multiple sclerosis patients

    • Souraya El Sankari
    • Cyril Van Essche
    • Vincent van Pesch

    Letter to the Editors 28 June 2021 Pages: 4376 - 4378

    

49. Neurological update: COVID-19

    • A. L. Ren
    • R. J. Digby
    • E. J. Needham

    Neurological Update Open access 30 April 2021 Pages: 4379 - 4387

    

50. Navigating migraine care through the COVID-19 pandemic: an update

    • Heather Angus-Leppan
    • Angelica E. Guiloff
    • Roberto J. Guiloff

    Neurological Update 17 May 2021 Pages: 4388 - 4395